Health and Fitness Health and Fitness
Tue, February 8, 2011
[ Tue, Feb 08th 2011 ] - Market Wire
Microbix'; CEO Statement on Universal Vaccine
[ Tue, Feb 08th 2011 ] - Market Wire
Marina Biotech, Inc. to Present at The 13th Annual BIO CEO & Investor Conference
[ Tue, Feb 08th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces XIBROM(TM) Shipments to Wholesalers to End on February 28, 2011
[ Tue, Feb 08th 2011 ] - Market Wire
Gilead Sciences Announces Notification of ANDA Filing for Tamiflu®
[ Tue, Feb 08th 2011 ] - Market Wire
ArQule, Inc. to Present at 13th Annual BIO CEO and Investor Conference
[ Tue, Feb 08th 2011 ] - Market Wire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
[ Tue, Feb 08th 2011 ] - Market Wire
XenoPort to Release Fourth Quarter and Year-End Financial Results on February 16, 2011
[ Tue, Feb 08th 2011 ] - Market Wire
Synergy Pharmaceuticals effectuera une pr©sentat .. la 13me conf©rence annuelle BIO CEO and Investor
[ Tue, Feb 08th 2011 ] - Market Wire
Synergy Pharmaceuticals auf der 13. BIO CEO and Investor Conference unter den Referenten
[ Tue, Feb 08th 2011 ] - Market Wire
PASOS PARA AYUDAR A QUE SU HIJO TENGA UNA SONRISA BRILLANTE
[ Tue, Feb 08th 2011 ] - Market Wire
Response Genetics, Inc. Announces Appointment of Company President
[ Tue, Feb 08th 2011 ] - Market Wire
Steps to Help Ensure Your Childa?s Bright Smile
Mon, February 7, 2011
[ Mon, Feb 07th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Emerge
[ Mon, Feb 07th 2011 ] - Market Wire
Liberty Metals & Mining Exercises Participation R .. 9 Million Financing for Further Proceeds of Up to
[ Mon, Feb 07th 2011 ] - Market Wire
00 A.M. EST
[ Mon, Feb 07th 2011 ] - Market Wire
FDA Approves Labeling Update for REYATAZ® (ataza .. lude Data Supporting the Recommended Adult Dose o
[ Mon, Feb 07th 2011 ] - Market Wire
Emeritus Signs Management Agreements with Columbia Pacific Advisors
[ Mon, Feb 07th 2011 ] - Market Wire
Tenet and Aetna Sign New National Multi-Year Agreement
[ Mon, Feb 07th 2011 ] - Market Wire
SANUWAVE Health Raises $4.1 Million
[ Mon, Feb 07th 2011 ] - Market Wire
FFF Enterprises Makes FluMist(R) by MedImmune a Key Addition to Its Flu Vaccine Portfolio
[ Mon, Feb 07th 2011 ] - Market Wire
2003 and ISO 9001:2008 Certifications
[ Mon, Feb 07th 2011 ] - Market Wire
Depomed's Reports Results of Phase 1 Trial of Twi .. ly Formulation of DM-1992 in Parkinson's Patients
[ Mon, Feb 07th 2011 ] - Market Wire
Progenics Pharmaceuticals and Salix Pharmaceutica .. nounce Worldwide License Agreement for RELISTOR®
[ Mon, Feb 07th 2011 ] - Market Wire
Proactive Interventions Reduce Hospital Admissions and Readmissions, Achieve Cost Savings
Sun, February 6, 2011
[ Sun, Feb 06th 2011 ] - Market Wire
Helix BioPharma Corp. Receives FDA IND Approval t .. ical Study With Its Lung Cancer Drug Candidate L-
Fri, February 4, 2011
[ Fri, Feb 04th 2011 ] - Market Wire
Universal American Corp. Schedules 2010 Fourth Qu .. Results Release and Conference Call for Thursday,
[ Fri, Feb 04th 2011 ] - Market Wire
XenoPort Announces New Employment Inducement Awards
[ Fri, Feb 04th 2011 ] - Market Wire
DaVita to Acquire DSI Renal, Inc.
[ Fri, Feb 04th 2011 ] - Market Wire
Sirona Reports Fiscal 2011 First Quarter Results
[ Fri, Feb 04th 2011 ] - Market Wire
Abiomed to Ring NASDAQ Closing Bell; Signifying S .. Heart Month and Celebrating a Successful Quarter
[ Fri, Feb 04th 2011 ] - Market Wire
US FDA Assigns New PDUFA Date for BRILINTA (ticagrelor tablets)
[ Fri, Feb 04th 2011 ] - Market Wire
SurModics to Webcast Annual Meeting on February 7
[ Fri, Feb 04th 2011 ] - Market Wire
Abiomed Announces Survey Results and Launches National Heart Recovery Awareness Campaign
[ Fri, Feb 04th 2011 ] - Market Wire
Allana Potash Increases Previously Announced Bought Deal to $27,900,000
[ Fri, Feb 04th 2011 ] - Market Wire
Aetna Board of Directors Increases Shareholder Dividend and Authorizes Quarterly Payment
[ Fri, Feb 04th 2011 ] - Market Wire
Continucare Corporation Reports Increased Revenue and Net Income for Second Quarter of Fiscal 2011
[ Fri, Feb 04th 2011 ] - Market Wire
Life Technologies Announces Fourth Quarter and Fiscal Year 2010 Results
Thu, February 3, 2011
[ Thu, Feb 03rd 2011 ] - Market Wire
Electromed, Inc. Second Quarter Earnings Call Scheduled for February 10, 2011
[ Thu, Feb 03rd 2011 ] - Market Wire
BIOLASE Receives CE Mark Approval for Waterlase(R) iPlus(TM) All-Tissue Laser
[ Thu, Feb 03rd 2011 ] - Market Wire
Will Geron & AEterna Zentaris Remain Healthcare "Winners"?
[ Thu, Feb 03rd 2011 ] - Market Wire
TomoTherapy to Announce Fourth Quarter Financial Results on Friday, February 18, 2011
[ Thu, Feb 03rd 2011 ] - Market Wire
Opinions on Gilead Sciences Inc. and GlaxoSmithKline plc -- A Look at R&D in the Health Industry
[ Thu, Feb 03rd 2011 ] - Market Wire
Cornerstone Therapeutics Appoints Chief Financial Officer
[ Thu, Feb 03rd 2011 ] - Market Wire
GSK and Theravance Announce Progression of LAMA/L .. ion Treatment Into Phase III Development for COPD
[ Thu, Feb 03rd 2011 ] - Market Wire
Implant Sciences Announces Force Protection Order Worth Over $200,000 to Customer in Europe
[ Thu, Feb 03rd 2011 ] - Market Wire
CONMED Corporation Announces Fourth Quarter and Full Year 2010 Financial Results
[ Thu, Feb 03rd 2011 ] - Market Wire
Hansen Medical and Philips Enter Agreements for t .. Applications of Fiber Optic Shape Sensing and Lo
[ Thu, Feb 03rd 2011 ] - Market Wire
Given Imaging Announces German Public Health Syst .. blish PillCam(R) SB Outpatient Reimbursement Code
[ Thu, Feb 03rd 2011 ] - Market Wire
Migraine Therapeutics Reviewed by NeuroInvestment
Wed, February 2, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
Radient Pharmaceuticals Completes Private Placeme .. ate Financing With Gross Proceeds of $7.5 Million
[ Wed, Feb 02nd 2011 ] - Market Wire
The Medicines Company to Announce Fourth Quarter .. Financial Results on Wednesday, February 16, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
Mesa Uranium Acquires Uranium Leases
[ Wed, Feb 02nd 2011 ] - Market Wire
MEDNAX to Present at UBS 21st Annual Global Healthcare Services Conference
[ Wed, Feb 02nd 2011 ] - Market Wire
Dyer & Berens LLP Files Class Action Lawsuit on B .. sed the Common Stock of MannKind Corporation Betw
[ Wed, Feb 02nd 2011 ] - Market Wire
CardioNet, Inc. to Release Fourth Quarter and Full Year 2010 Earnings Results on February 17, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
ImmunoCellular Therapeutics Announces First Patient Enrolled In Its Phase II Trial of ICT-107
[ Wed, Feb 02nd 2011 ] - Market Wire
Harper Creek Drill Hole HC10-79 Extends Mineralization Beyond Previously Identified Eastern Limit
[ Wed, Feb 02nd 2011 ] - Market Wire
Aberdeen International to Release 2010 Fourth Qua .. er/Year-End Portfolio Update on February 16, 2011
[ Wed, Feb 02nd 2011 ] - Market Wire
Trinity Biotech Announces the Acquisition of Phoenix Biotech
[ Wed, Feb 02nd 2011 ] - Market Wire
NMT Medical Announces Plans to Begin Trading on OTCQB Marketplace
[ Wed, Feb 02nd 2011 ] - Market Wire
Novo Nordisk increased operating profit by 27% in 2010
Tue, February 1, 2011
[ Tue, Feb 01st 2011 ] - Market Wire
Five Star Quality Care, Inc. to Present at the UB .. ealthcare Services Conference on February 7, 2011
[ Tue, Feb 01st 2011 ] - Market Wire
Izard Nobel LLP Announces Class Action Lawsuit Against MannKind Corporation
[ Tue, Feb 01st 2011 ] - Market Wire
Arius3D Corp. Establishes a 3D Imaging Centre at the University of South Carolina
[ Tue, Feb 01st 2011 ] - Market Wire
Lightlake Therapeutics Takes Safer Approach to Obesity
[ Tue, Feb 01st 2011 ] - Market Wire
CORRECTING andREPLACING Biogen Idec Reports Full Year and Fourth Quarter 2010 Results
[ Tue, Feb 01st 2011 ] - Market Wire
Covidien Reports First-Quarter Results
[ Tue, Feb 01st 2011 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2011
[ Tue, Feb 01st 2011 ] - Market Wire
10 Canadian Tech Stocks to Watch in 2011
[ Tue, Feb 01st 2011 ] - Market Wire
European Union (EMEA) Approves Lead Therapeutics Drug From Global Health Ventures Inc.
[ Tue, Feb 01st 2011 ] - Market Wire
Rosetta Genomics Advances Development of Its Body .. ased Diagnostic Tests With Two New Collaborations
[ Tue, Feb 01st 2011 ] - Market Wire
Aoxing Pharmaceutical Company Appoints Bob Ai as Chief Financial Officer
[ Tue, Feb 01st 2011 ] - Market Wire
Transdel Pharmaceuticals Announces Exploration of Strategic Alternatives
Mon, January 31, 2011
[ Mon, Jan 31st 2011 ] - Market Wire
KCI neemt licentie op merk GRAFTJACKET voor wondverzorging van Wright Medical
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutida) cumple el criterio princip .. estudio fundamental de Fase 3 en pacientes adult
[ Mon, Jan 31st 2011 ] - Market Wire
Wright Medical Group, Inc. Announces Expansion of Relationship with Kinetic Concepts, Inc.
[ Mon, Jan 31st 2011 ] - Market Wire
Humana Extends National Agreement to Offer Healthwaysa? SilverSneakers® Fitness Program
[ Mon, Jan 31st 2011 ] - Market Wire
CompCare Appoints Leading Healthcare Consultant, David Pitts, to its Board of Directors
[ Mon, Jan 31st 2011 ] - Market Wire
Sound Surgical Technologies to Promote Cytori's P .. ) System -- the Latest Innovation in Fat Grafting
[ Mon, Jan 31st 2011 ] - Market Wire
Covidien and Masimo Announce Extension of Royalty Agreement
[ Mon, Jan 31st 2011 ] - Market Wire
Repligen Announces Conference Call of Third Quarter Fiscal Year 2011 Results
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (Teduglutid) erreicht primren Wirksamkei .. 3-Studie mit erwachsenen Patienten mit Kurzdarmsy
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutide) Meets Primary Efficacy End .. Study in Patients with Adult Short Bowel Syndrome
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutide) soddisfa l'endpoint primar .. ruciale di fase 3 per i pazienti adulti affetti d
[ Mon, Jan 31st 2011 ] - Market Wire
GATTEX® (teduglutide) voldoet aan primair eindpu .. se 3 hoofdstudie in volwassen pati?nten met korte
Sun, January 30, 2011
[ Sun, Jan 30th 2011 ] - Market Wire
Dr. Reddya?s Provides Update on the Fexofenadine-Pseudoephedrine 24 Hour Litigation
[ Sun, Jan 30th 2011 ] - Market Wire
CORRECTING and REPLACING Wright Medical Group, In .. Host Fourth Quarter 2010 Earnings Conference Call
Fri, January 28, 2011
[ Fri, Jan 28th 2011 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES FOURTH QUARTER AND YEAR-END FINANCIALS
[ Fri, Jan 28th 2011 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Obtains Court Ord .. ection with Previously Announced CCAA Proceedings
[ Fri, Jan 28th 2011 ] - Market Wire
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
[ Fri, Jan 28th 2011 ] - Market Wire
GTSO Names John Shearer President and CEO
[ Fri, Jan 28th 2011 ] - Market Wire
Incyte to Report 2010 Financial Results and Provi .. Objectives and Financial Guidance on February 10
[ Fri, Jan 28th 2011 ] - Market Wire
Greatbatch, Inc. to Host Investor Day on March 24, 2011
Thu, January 27, 2011
[ Thu, Jan 27th 2011 ] - Market Wire
(NASDAQ: KERX) Rated a "BUY" by 5 Wall Street Firms
[ Thu, Jan 27th 2011 ] - Market Wire
Covidien entrega la plataforma de energa nmero 20.000 ForceTriadTM
[ Thu, Jan 27th 2011 ] - Market Wire
RTI Biologics Schedules 2010 Fourth Quarter, Year .. End Earnings and Conference Call for Feb. 3, 2011
[ Thu, Jan 27th 2011 ] - Market Wire
Marina Biotech Announces Issuance of Patent Cover .. ng Peptide Technology From the Japanese Patent Of
[ Thu, Jan 27th 2011 ] - Market Wire
Celgene Reports Record Non-GAAP Fourth Quarter and Full Year 2010 Operating and Financial Results
[ Thu, Jan 27th 2011 ] - Market Wire
Emeritus and Columbia Pacific Advisors to Explore Opportunities For Senior Housing in China
[ Thu, Jan 27th 2011 ] - Market Wire
RXi Pharmaceuticals Announces Positive Initial Results in microRNA Therapeutics
[ Thu, Jan 27th 2011 ] - Market Wire
Patient Home Monitoring Announces Sales Pipeline Update
[ Thu, Jan 27th 2011 ] - Market Wire
Newly Published Data Demonstrates Caldolor® Sign .. Pain and Morphine Use in Post-Operative Patients
[ Thu, Jan 27th 2011 ] - Market Wire
Covidien levert 20.000ste ForceTriad energieplatform
[ Thu, Jan 27th 2011 ] - Market Wire
Covidien livre sa 20.000me plateforme ©nerg©tique ForceTriadTM
[ Thu, Jan 27th 2011 ] - Market Wire
IDC PARTICIPATES IN CANADIAN GOVERNMENT LED TRADE MISSION TO SAUDI ARABIA
Wed, January 26, 2011
[ Wed, Jan 26th 2011 ] - Market Wire
Covidien liefert das 20.000. Exemplar seiner ForceTriadTM-Energieplattform aus
[ Wed, Jan 26th 2011 ] - Market Wire
NeuroMetrix, Inc. Announces Date for 2010 Fourth Quarter Financial Results Conference Call
[ Wed, Jan 26th 2011 ] - Market Wire
Radient Pharmaceuticals Receives NYSE Amex Notice of Delisting for Non-Compliance
[ Wed, Jan 26th 2011 ] - Market Wire
Covidien Delivers 20,000th ForceTriadTM Energy Platform
[ Wed, Jan 26th 2011 ] - Market Wire
Altra Investments and The Rohatyn Group Sell Controlling Stake in Infarmasa
[ Wed, Jan 26th 2011 ] - Market Wire
Teva to Acquire Corporacin Infarmasa
[ Wed, Jan 26th 2011 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Announces Receipt of Notice of Termination From Rex Medical L.P.
[ Wed, Jan 26th 2011 ] - Market Wire
IDC ENTERS INTO CAD $3 MILLION STOCK PURCHASE GUARANTEE TERM SHEET
[ Wed, Jan 26th 2011 ] - Market Wire
St. Jude Medical Reports Fourth Quarter and Full-Year 2010 Results
[ Wed, Jan 26th 2011 ] - Market Wire
Gilead Sciences riceve una notifica da parte dell .. i Medicinali statunitense (Food and Drug Administ
[ Wed, Jan 26th 2011 ] - Market Wire
Health Management Associates, Inc. Announces Four .. ear-End 2010 Earnings Conference Call and Webcast
[ Wed, Jan 26th 2011 ] - Market Wire
Gilead Sciences erhlt aRefuse-to-Filea-Mitteilung .. sung fr Einzeltablettentherapie mit Truvada® und
Tue, January 25, 2011
[ Tue, Jan 25th 2011 ] - Market Wire
St. Jude erhlt CE-Zertifizierung fr Produktion in Malaysia
[ Tue, Jan 25th 2011 ] - Market Wire
St. Jude Medical recibe aprobacin de marca CE para fabricacin en Malasia
[ Tue, Jan 25th 2011 ] - Market Wire
LABOPHARM ANNOUNCES EXECUTIVE APPOINTMENTS
[ Tue, Jan 25th 2011 ] - Market Wire
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Fourth Quarter and Year-End 2010
[ Tue, Jan 25th 2011 ] - Market Wire
SANUWAVE Health Granted U.S. Patent on Use of Pie .. roduce Acoustic Energy in the Shock Wave Spectrum
[ Tue, Jan 25th 2011 ] - Market Wire
Milestone Scientific Signs Agreement with Towncar .. . for Its STA Single Tooth Anesthesia Instruments
[ Tue, Jan 25th 2011 ] - Market Wire
International Stem Cella?s Scientists in Collabor .. Cell Experts Extend Understanding of Human Parth
[ Tue, Jan 25th 2011 ] - Market Wire
Alnylam Receives Positive Opinion for Orphan Drug .. dicines Agency for ALN-TTR01, an RNAi Therapeutic
[ Tue, Jan 25th 2011 ] - Market Wire
BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine
[ Tue, Jan 25th 2011 ] - Market Wire
Emergent BioSolutions Announces Initiation of Pha .. Combination with Bendamustine for Chronic Lymphoc
[ Tue, Jan 25th 2011 ] - Market Wire
Illumina to Announce Fourth Quarter and Fiscal Ye .. 10 Financial Results on Tuesday, February 8, 2011
[ Tue, Jan 25th 2011 ] - Market Wire
Dr. Reddya?s Q3 FY11 Financial Results
Mon, January 24, 2011
[ Mon, Jan 24th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Genoptix, Inc.
[ Mon, Jan 24th 2011 ] - Market Wire
Thermo Fisher Scientific Notifies Holders of 3.25 .. f Option to Require the Company to Purchase Notes
[ Mon, Jan 24th 2011 ] - Market Wire
Brower Piven Announces an Investigation of the Acquisition of Genoptix, Inc. by Novartis AG
[ Mon, Jan 24th 2011 ] - Market Wire
Aetna Statement on Award to Board Member Gerald Greenwald
[ Mon, Jan 24th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Genopt
[ Mon, Jan 24th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Investigates Genoptix, Inc. Buyout
[ Mon, Jan 24th 2011 ] - Market Wire
Kendall Law Group Investigates Genoptix, Inc. Acquisition for Shareholders
[ Mon, Jan 24th 2011 ] - Market Wire
Furiex Receives FDA Fast Track Designation of MuD .. of Diarrhea-Predominant Irritable Bowel Syndrome
[ Mon, Jan 24th 2011 ] - Market Wire
CHINA HEALTH LABS &; DIAGNOSTICS LTD. ANNOUNCES NEW CUSTOMER FOR POCT DIAGNOSTICS FIELD LABS
[ Mon, Jan 24th 2011 ] - Market Wire
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
[ Mon, Jan 24th 2011 ] - Market Wire
Medisafe 1 Technologies Expects Revenues to Exceed $10M in 2012
[ Mon, Jan 24th 2011 ] - Market Wire
Norman Nichols Named President of Molina Medicaid Solutions
Sun, January 23, 2011
[ Sun, Jan 23rd 2011 ] - Market Wire
Teva Enters Into $1.5 Billion Syndicated Credit Facility
Sat, January 22, 2011
[ Sat, Jan 22nd 2011 ] - Market Wire
Biogen Idec ontvangt negatief advies van CHMP over FAMPYRA
Fri, January 21, 2011
[ Fri, Jan 21st 2011 ] - Market Wire
FAMPYRA de Biogen Idec reoit un avis d©favorable du CHMP
[ Fri, Jan 21st 2011 ] - Market Wire
Biogen Idec riceve l'opinione negativa sul FAMPYRA da parte del CHMP
[ Fri, Jan 21st 2011 ] - Market Wire
Negative Stellungnahme vom Ausschuss fr Humanarzneimittel zu FAMPYRA
[ Fri, Jan 21st 2011 ] - Market Wire
Genomic Health Announces Multiple Colon Cancer St .. of Clinical Oncology Gastrointestinal Cancers Sy
[ Fri, Jan 21st 2011 ] - Market Wire
Health Net Partners with Blue Star Families and T .. Survivors to Help Prevent Suicide Among Military
[ Fri, Jan 21st 2011 ] - Market Wire
CardioMEMS Recognized by Georgia Bio for Pivotal Strategic Partnership
[ Fri, Jan 21st 2011 ] - Market Wire
Dr. Charles E. Saunders to Lead Aetnaa?s Strategic Diversification Efforts
[ Fri, Jan 21st 2011 ] - Market Wire
Tenet to Release Fourth Quarter Results on February 25, 2011
[ Fri, Jan 21st 2011 ] - Market Wire
Biogen Idec recibe opinin negativa del CHMP sobre FAMPYRA
[ Fri, Jan 21st 2011 ] - Market Wire
Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc. to January 28, 2011
[ Fri, Jan 21st 2011 ] - Market Wire
Human Genome Sciences Appoints Greg Norden to Its Board of Directors
[ Fri, Jan 21st 2011 ] - Market Wire
AVEO Pharmaceuticalsa? Tivozanib Clinical Data Fe .. d at 2011 ASCO Gastrointestinal Cancers Symposium
Thu, January 20, 2011
[ Thu, Jan 20th 2011 ] - Market Wire
LABOPHARM RECEIVES HEALTH CANADA APPROVAL FOR OLE .. TIDEPRESSANT FOR THE TREATMENT OF MAJOR DEPRESSIV
[ Thu, Jan 20th 2011 ] - Market Wire
Anika Therapeutics Appoints Industry Veteran Jeffery S. Thompson to Board of Directors
[ Thu, Jan 20th 2011 ] - Market Wire
Dr. Reddya?s Announces the Launch of Pantoprazole Sodium Delayed-Released Tablets
[ Thu, Jan 20th 2011 ] - Market Wire
Obagi Medical Products Wins Two Awards in the Fir .. Annual Beauty Choice Awards by NewBeauty Magazine
[ Thu, Jan 20th 2011 ] - Market Wire
Covidien meldet Einfhrung des tragbaren Beatmungsgerts Puritan Bennetta" 520 in Europa
[ Thu, Jan 20th 2011 ] - Market Wire
UnitedHealth Group Announces Next Phase in Health .. Services Organizations, and New Leadership Roles
[ Thu, Jan 20th 2011 ] - Market Wire
Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®
[ Thu, Jan 20th 2011 ] - Market Wire
Spectranetics Receives FDA Approval for Site Chan .. elated to Manufacturing of CVX-300® Laser System
[ Thu, Jan 20th 2011 ] - Market Wire
ZIOPHARM Receives Positive Opinion for Orphan Dru .. n for Darinaparsin from European Medicines Agency
[ Thu, Jan 20th 2011 ] - Market Wire
Covidien maakt de lancering bekend van de draagba .. beademingsmachine Puritan Bennetta" 520 in Europa
[ Thu, Jan 20th 2011 ] - Market Wire
Covidien annuncia il lancio in Europa del ventilatore portatile Puritan Bennetta" 520
[ Thu, Jan 20th 2011 ] - Market Wire
Covidien annonce le lancement en Europe du ventilateur portable Puritan Bennetta" 520
Wed, January 19, 2011
[ Wed, Jan 19th 2011 ] - Market Wire
Journal of Clinical Oncology Publishes Results fr .. y of FOLOTYN® in Relapsed or Refractory Peripher
[ Wed, Jan 19th 2011 ] - Market Wire
PPD Issues 2011 Financial Guidance
[ Wed, Jan 19th 2011 ] - Market Wire
ArQule Announces Proposed Public Offering
[ Wed, Jan 19th 2011 ] - Market Wire
SurModics to Webcast First Quarter Fiscal Year 2011 Earnings Conference Call January 26
[ Wed, Jan 19th 2011 ] - Market Wire
MannKind Corporation Receives Complete Response Letter from the FDA for AFREZZA®
[ Wed, Jan 19th 2011 ] - Market Wire
INVESTOR INTERVIEW WITH PATIENT HOME MONITORING CEO ED BERENBLUM POSTED ON PHM WEB SITE
[ Wed, Jan 19th 2011 ] - Market Wire
Illumina abrir escritrio na Am©rica Latina
[ Wed, Jan 19th 2011 ] - Market Wire
Illumina abrir una oficina en Latinoam©rica
[ Wed, Jan 19th 2011 ] - Market Wire
Teva Congratulates Professor Moussa Youdim, Winner of the 2010 EMET Prize for Brain Science
[ Wed, Jan 19th 2011 ] - Market Wire
LifeVantage Announces Preliminary Unaudited Second Quarter 2011 Results
[ Wed, Jan 19th 2011 ] - Market Wire
Geron Initiates Phase 2 Clinical Trial of Imetelstat in Essential Thrombocythemia
Tue, January 18, 2011
[ Tue, Jan 18th 2011 ] - Market Wire
Illumina Launches the Illumina Agricultural Great .. lp Reduce Global Hunger, Malnutrition and Poverty
[ Tue, Jan 18th 2011 ] - Market Wire
Centric Health Comments on Recent Market Activity
[ Tue, Jan 18th 2011 ] - Market Wire
IntegraMed Expands Fertility Partner Network via Acquisition of Seattle, WA Fertility Center
[ Tue, Jan 18th 2011 ] - Market Wire
Baeta Corp. Chosen as Best Stock Pick of the Year by Prominent Hedge Fund
[ Tue, Jan 18th 2011 ] - Market Wire
Biomoda Featured on Business Radio
[ Tue, Jan 18th 2011 ] - Market Wire
ARIAD Announces Oral Ridaforolimus Achieved Prima .. ression-Free Survival in Patients with Metastatic
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien introduceert nieuwe generatie EverFlex+ Peripheral Stent System
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien revela el sistema de stents perif©ricos EverFlex+a" de prxima generacin
[ Tue, Jan 18th 2011 ] - Market Wire
Creative Learning Corporation Continues Its International Expansion
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien d©voile son systme de stent p©riph©rique EverFlex+a" de nouvelle g©n©ration
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien stellt EverFlex+a" vor, sein peripheres Stentsystem der nchsten Generation
Mon, January 17, 2011
[ Mon, Jan 17th 2011 ] - Market Wire
Covidien Unveils Next Generation EverFlex+a" Peripheral Stent System
[ Mon, Jan 17th 2011 ] - Market Wire
Leisureworld Announces January Dividend
[ Mon, Jan 17th 2011 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. nings Release Date for Thursday, February 3, 2011
[ Mon, Jan 17th 2011 ] - Market Wire
Emeritus Announces Appointment of Granger Cobb as Chief Executive Officer
[ Mon, Jan 17th 2011 ] - Market Wire
The State of Israel's Nationwide Blood Banks Comm .. isafe 1 Technologies Corporation's Pre-Matching D
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
Biogen Idec to Report Fourth Quarter and Year End 2010 Financial Results on February 1, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
Tenet Issues Statement Regarding Community Health Director Nominees
[ Fri, Jan 14th 2011 ] - Market Wire
Community Health Systems to Nominate Full Slate o .. tors for Election at Teneta?s 2011 Annual Meeting
[ Fri, Jan 14th 2011 ] - Market Wire
Health Canada Requests Additional Information to Support Application for Approval of Prochymal
[ Fri, Jan 14th 2011 ] - Market Wire
Thermo Fisher Scientific Extends Cash Tender Offer for Dionex Corporation
[ Fri, Jan 14th 2011 ] - Market Wire
ICON Acquires Oxford Outcomes

Covidien and Masimo Announce Extension of Royalty Agreement


Published on Monday, January 31st 2011 at 4:05 GMT by Market Wire   Print publication without navigation


MANSFIELD, Mass.--([ BUSINESS WIRE ])--Covidien (NYSE: COV) and Masimo today announced that they have amended the existing settlement agreement initially reached in January 2006. Under the terms of the amendment, Covidien will pay Masimo a royalty of 7.75% for its current pulse oximetry products sold in the United States for three years, beginning March 15, 2011.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit [ www.covidien.com ] to learn more about our business.


Publication Contributing Sources